Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed-Reference-Cited by-同舟云学术

Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed

Published:2015-02-04 Issue:7 Volume:41 Page:613-623
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Gisbert J. P.¹²^ORCID,Marín A. C.¹²,McNicholl A. G.¹²,Chaparro M.¹²

Affiliation:

1. Gastroenterology Unit; Hospital Universitario de La Princesa and Instituto de Investigación Sanitaria Princesa (IIS-IP); Madrid Spain

2. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD); Madrid Spain

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13083/fullpdf

Reference76 articles.

1. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials;Peyrin-Biroulet;Clin Gastroenterol Hepatol,2008

2. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial;Hanauer;Lancet,2002

3. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial;Colombel;Gastroenterology,2007

4. Maintenance therapy with certolizumab pegol for Crohn's disease;Schreiber;N Engl J Med,2007

5. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease;Lichtenstein;Gastroenterology,2005

Cited by 259 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of filgotinib in ulcerative colitis and Crohn’s disease;Immunotherapy;2024-02

2. Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn’s Disease: A Belgian Multicentric Cohort Study;Inflammatory Bowel Diseases;2024-01-12

3. Efficacy of infliximab after loss of response of/intolerance to adalimumab in pediatric Crohn's disease: A retrospective multicenter cohort study of the “GETAID pédiatrique”;Journal of Pediatric Gastroenterology and Nutrition;2024-01-07

4. Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus;BMJ Open Gastroenterology;2024-01

5. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry;Therapeutic Advances in Gastroenterology;2024-01